| Real-World Data Collection of GORE Devices Used In the Endovascular Treatment of Aortic Aneurysms Which Incorporate Visceral Arteries. (NCT07480395) | W.L.Gore & Associates | 2026-12-01 |
| The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study (NCT07538609) | W.L.Gore & Associates | 2026-10-07 |
| Assessment of GORE® EXCLUDER® IBE Plus Stent Graft Performance in Patients Undergoing Endovascular Iliac Revascularization (NCT07304102) | W.L.Gore & Associates | 2026-09-01 |
| MBA Early Feasibility Study (NCT07564375) | W.L.Gore & Associates | 2026-09-01 |
| TBE Zone 0/1 PMS in Japan (NCT07691931) | W.L.Gore & Associates | 2026-09-01 |
| VIATORR® TIPS Study Evaluating 6-10mm Diameters (VIATIPS) (NCT07390344) | W.L.Gore & Associates | 2026-06-01 |
| GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Post-Market Clinical Follow-Up (PMCF) Observational Registry (RE-PROVE) (NCT07279649) | W.L.Gore & Associates | 2026-05-08 |
| TAMBE Japan Post-Marketing Surveillance (NCT07147569) | W.L.Gore & Associates | 2026-03-27 |
| GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study (NCT07166133) | W.L.Gore & Associates | 2026-03-02 |
| TBE Zone 2 PMS in Japan (NCT07049913) | W.L.Gore & Associates | 2025-12-15 |
| GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections (NCT06827990) | W.L.Gore & Associates | 2025-09-22 |
| Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance (NCT06658730) | W.L.Gore & Associates | 2025-06-19 |
| Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease (NCT06872905) | W.L.Gore & Associates | 2025-05-30 |
| Post Market Registry for GORE® TAG® Thoracic Branch Endoprosthesis (NCT06507865) | W.L.Gore & Associates | 2025-02-20 |
| Clinical Outcomes of the Gore Synthetic Cornea Device (NCT06174376) | W.L.Gore & Associates | 2024-08-19 |
| Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis (NCT06218875) | W.L.Gore & Associates | 2024-05-07 |
| GORE® VIABIL® Biliary Endoprosthesis in the Treatment of Benign Biliary Strictures Secondary to Chronic Pancreatitis (NCT05820009) | W.L.Gore & Associates | 2024-02-01 |
| Registry of GORE® ACUSEAL Vascular Graft in Dialysis Access (NCT05846581) | W.L.Gore & Associates | 2024-01-12 |
| Evaluation of the GORE® Ascending Stent Graft (NCT05800743) | W.L.Gore & Associates | 2023-11-28 |
| The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study (NCT05489588) | W.L.Gore & Associates | 2023-03-02 |
| Assessment of GORE® SYNECOR Biomaterial in Focused Patient Populations and Long-Term Application (NCT05094089) | W.L.Gore & Associates | 2023-02-24 |
| VIATORR Device Registry (NCT05661331) | W.L.Gore & Associates | 2023-02-21 |
| The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study (NCT05409976) | W.L.Gore & Associates | 2022-10-25 |
| Japan Post Marketing Surveillance of the GORE® CARDIOFORM Septal Occluder (NCT05529901) | W.L.Gore & Associates | 2022-10-03 |
| GORE Glaucoma Drainage Implant Clinical Study Dominican Republic (NCT05557058) | W.L.Gore & Associates | 2022-09-14 |
| Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used as a Bridging Stent With Branched and Fenestrated Endografts in the Treatment of Aortic Aneurysms Involving the Renal-Mesenteric Arteries (NCT05143138) | W.L.Gore & Associates | 2022-03-23 |
| Retrospective Post-Market Clinical Follow-Up Study of GORE-TEX® Vascular Grafts and GORE® PROPATEN® Vascular Graft in Peripheral Artery Disease, Aortic Aneurysms, and Dialysis Access (NCT05124184) | W.L.Gore & Associates | 2022-01-24 |
| Observational GORE® VIABAHN® Endoprosthesis With PROPATEN Bioactive Surface Global Registry (NCT04907240) | W.L.Gore & Associates | 2021-10-09 |
| GORE® ENFORM Biomaterial Product Study (NCT04718168) | W.L.Gore & Associates | 2021-05-17 |
| GORE® CARDIOFORM Septal Occluder Migraine Clinical Study (NCT04100135) | W.L.Gore & Associates | 2021-02-05 |
| A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease (NCT04671771) | W.L.Gore & Associates | 2020-12-03 |
| GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study (NCT04429243) | W.L.Gore & Associates | 2020-07-02 |
| GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study (NCT03821129) | W.L.Gore & Associates | 2019-07-25 |
| Evaluating the Safety and Effectiveness of the InnAVasc Graft for Dialysis Access in Patients With Kidney Failure (NCT03645681) | W.L.Gore & Associates | 2019-01-02 |
| Evaluation of the GORE PV1 Device in Patients With Pulmonary Valve Dysfunction (NCT03441971) | W.L.Gore & Associates | 2018-06-07 |
| Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms (NCT02489539) | W.L.Gore & Associates | 2017-12-19 |
| Observational Registry Characterizing the CTAG Device With ACTIVE CONTROL (NCT03286400) | W.L.Gore & Associates | 2017-10-18 |